Trials / Completed
CompletedNCT01710059
Using Mobile Phones to Improve Adherence to Inhaled Steroids
Refined ADEPT: Human Augmentics for Sustained Wellbeing
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Rush University Medical Center · Academic / Other
- Sex
- All
- Age
- 11 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
This study has two main goals. The first goal is to test whether a mobile phone intervention can increase adherence to daily inhaled steroid medications in African American adolescents prescribed this type of medication by his/her asthma doctor. The second goal is to use a mobile phone intervention to better understand real life patterns of use of quick-relief (beta2-adrenergic agonist) asthma medication in this population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Asthma Supervision | Each participant will be provided with a spacer and a peak flow meter, and instructions on proper technique, by a member of the study team during the baseline period. They will also meet with study staff at study visits during the active treatment phase to review their adherence to daily inhaled corticosteroids and usage patterns of short acting B2-agonist medication. |
| BEHAVIORAL | Mobile Phone | Each participant will receive a mobile phone with talking, texting and a data plan. They will get to keep the mobile phone at the end of the study, but the talking, texting and data plan will only be active during their participation in the study. |
| BEHAVIORAL | Inhaled Corticosteroid Mobile Phone Application | The Inhaled Corticosteroid Mobile Phone Application will be used to provide virtual doctor supervision, immediate feedback, and positive reinforcement for taking inhaled corticosteroid medication as indicated. |
| BEHAVIORAL | Beta2-adrenergic agonist Mobile Phone Application | The Beta2-adrenergic agonist Mobile Phone Application will be used to track real time patterns of use of beta2-adrenergic agonist medication. |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2012-10-18
- Last updated
- 2014-02-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01710059. Inclusion in this directory is not an endorsement.